anagrelid nordic 0.5 mg comprimés
nordic pharma gmbh - anagrelidum - comprimés - anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, lactosum 44.39 mg, povidonum k 30, cellulosum microcristallinum, crospovidonum, magnesii stearas, pro compresso. - essentiels thrombozythämie - synthetika
anagrelid nordic 0.75 mg comprimés
nordic pharma gmbh - anagrelidum - comprimés - anagrelidum 0.75 mg ut anagrelidi hydrochloridum monohydricum, lactosum 66.58 mg, povidonum k 30, cellulosum microcristallinum, crospovidonum, magnesii stearas, pro compresso. - essentiels thrombozythämie - synthetika
anagrelid nordic 1.0 mg comprimés
nordic pharma gmbh - anagrelidum - comprimés - anagrelidum 1 mg ut anagrelidi hydrochloridum monohydricum, lactosum 88.78 mg, povidonum k 30, cellulosum microcristallinum, crospovidonum, magnesii stearas, pro compresso. - essentiels thrombozythämie - synthetika
xagrid 0,5 mg gélules
takeda pharma ag - anagrelidum - gélules - anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, povidonum k 30, lactosum 65.76 mg, lactosum monohydricum 53.74 mg, cellulosum microcristallinum, crospovidonum, magnesii stearas, kapselhülle: gelatina, e 171, drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, e 172 (nigrum), pro capsula. - traitement des essentiels thrombozythämie - synthetika
thromboreductin 0.5 mg capsules
orpha swiss gmbh - anagrelidum - capsules - anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, lactosum monohydricum 93.9 mg, povidonum k 29-32, crospovidonum, cellulosum microcristallinum, magnesii stearas, kapselhülle: gelatina, aqua, e 171, e 132, pro capsula. - traitement des essentiels thrombozythämie - synthetika
thromboreductin 1 mg capsules
orpha swiss gmbh - anagrelidum - capsules - anagrelidum 1 mg à anagrelidi hydrochloridum monohydricum, lactosum monohydricum 93.33 mg, povidonum k 29-32, crospovidonum, cellulosum microcristallinum, magnésium stearas, kapselhülle: gélatine, eau, e 171, pour une petite boîte. - traitement des essentiels thrombozythämie - synthetika
anagrelide orpha 0.5mg capsules
orpha swiss gmbh - anagrelidum - capsules - anagrelidum 0.5 mg ut anagrelidi hydrochloridum monohydricum, color.: e 132, excipiens pro capsula. - traitement des essentiels thrombozythämie - synthetika
anagrelide orpha 1.0mg capsules
orpha swiss gmbh - anagrelidum - capsules - anagrelidum 1 mg ut anagrelidi hydrochloridum monohydricum, excipiens pro capsula. - traitement des essentiels thrombozythämie - synthetika
pms-anagrelide capsule
pharmascience inc - anagrélide (chlorhydrate d'anagrélide monohydraté) - capsule - 0.5mg - anagrélide (chlorhydrate d'anagrélide monohydraté) 0.5mg - platelet-reducing agents
mylan-anagrelide capsule
mylan pharmaceuticals ulc - anagrélide (chlorhydrate d'anagrélide) - capsule - 0.5mg - anagrélide (chlorhydrate d'anagrélide) 0.5mg - platelet-reducing agents